Vivoryon Therapeutics NV (VVY) — Working Capital to Net Assets Ratio
Vivoryon Therapeutics NV (VVY) has a Working Capital to Net Assets ratio of 118.3% as of December 2025. Working capital of €5.59 Million (current assets of €6.43 Million minus current liabilities of €837.00K) is measured against net assets of €4.73 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. For the complete balance sheet picture, see Vivoryon Therapeutics NV total assets.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Vivoryon Therapeutics NV Working Capital to Net Assets (2010–2025)
This chart shows how Vivoryon Therapeutics NV's Working Capital to Net Assets ratio has evolved across 16 annual periods from 2010 to 2025. As of December 2025, the ratio stands at 118.3%, reflecting working capital of €5.59 Million against net assets of €4.73 Million EUR. Check how high is Vivoryon Therapeutics NV's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Annual Working Capital to Net Assets for Vivoryon Therapeutics NV (2010–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Vivoryon Therapeutics NV from 2010 to 2025, covering 16 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Read how much debt does Vivoryon Therapeutics NV carry for a breakdown of total debt and financial obligations.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 118.3% | €5.59 Million | €4.73 Million | €6.43 Million | €837.00K | ▲ +8.3 pp |
| 2024 | 110.0% | €8.67 Million | €7.88 Million | €10.07 Million | €1.40 Million | ▲ +8.7 pp |
| 2023 | 101.3% | €26.63 Million | €26.28 Million | €29.81 Million | €3.18 Million | ▼ -2.2 pp |
| 2022 | 103.5% | €27.43 Million | €26.51 Million | €30.69 Million | €3.27 Million | ▲ +11.8 pp |
| 2021 | 91.7% | €15.18 Million | €16.56 Million | €20.23 Million | €5.05 Million | ▼ -13.1 pp |
| 2020 | 104.8% | €27.47 Million | €26.22 Million | €28.79 Million | €1.32 Million | ▲ +0.6 pp |
| 2019 | 104.2% | €44.45 Million | €42.66 Million | €45.38 Million | €930.00K | ▼ -141.2 pp |
| 2018 | 245.4% | €3.02K | €1.23K | €3.98K | €964.00 | ▲ +133.0 pp |
| 2017 | 112.4% | €10.03K | €8.92K | €10.69K | €668.00 | ▲ +8.2 pp |
| 2016 | 104.2% | €17.06K | €16.38K | €22.20K | €5.14K | ▼ -0.1 pp |
| 2015 | 104.2% | €16.82K | €16.13K | €21.73K | €4.91K | ▼ -0.4 pp |
| 2014 | 104.7% | €16.71K | €15.97K | €21.29K | €4.58K | ▲ +24.5 pp |
| 2013 | 80.1% | €-3.38 Million | €-4.22 Million | €5.95 Million | €9.33 Million | ▼ -21.3 pp |
| 2012 | 101.4% | €5.44 Million | €5.37 Million | €9.01 Million | €3.57 Million | ▲ +48.5 pp |
| 2011 | 52.8% | €7.90 Million | €14.95 Million | €11.03 Million | €3.14 Million | ▲ +16.1 pp |
| 2010 | 36.8% | €4.50 Million | €12.24 Million | €7.59 Million | €3.09 Million | — |